Log in to search using one of your social media accounts:


Hodgkin’s lymphoma symptoms: Signs of the cancer you should know

HODGKIN ’S lymphoma is a form of cancer which develops in the lymphatic system - which is part of the immune system.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news

Related Links:

Abstract The authors present a proposal of a partnership between the Sociedade Brasileira de Oncologia Pedi átrica (SOBOPE) and the International Society of Pediatric Oncology (SIOP) to promote the standardization and improvement of nutritional care of kids under cancer treatment in Brazil. The results of the first meeting in Brazil as well as plans for future meetings are described.
Source: Revista Brasileira de Hematologia e Hemoterapia - Category: Hematology Source Type: research
The headaches began in March. The couple didn’t think much of them — until Carrie DeKlyen began vomiting. An initial scan showed a mass in her brain. More tests showed that it was a form of cancer, possibly lymphoma, but treatable. But a pathology exam revealed a more grim diagnosis. The 37-year-old mother of five from Wyoming, […]Related:Primal screams, blood and burns: What it’s like to survive a lightning strikeIvanka Trump reveals struggles with postpartum depression on ‘Dr. Oz’Could some ADHD be a type of sleep disorder? That would fundamentally change how we treat it.
Source: Washington Post: To Your Health - Category: Consumer Health News Source Type: news
Conclusions In older patients (≥60 years) with stage I/II HL, combination of chemotherapy and consolidative radiation resulted in improved OS as compared to monotherapy. However, utilization of combination therapy in this age group seems suboptimal. It could be partly secondary to comorbidities limiting the use of CT+RT in elderly. Teaser Early stage Hodgkin lymphoma is a highly curable malignancy. However, outcomes for elderly patients remain suboptimal. We conducted a retrospective study using the National Cancer Database to assess therapies used among elderly patients with early stage Hodgkin lymphoma from 2004-2012....
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Cutaneous T-cell lymphoma (CTCL) is an incurable non-Hodgkin lymphoma of the skin-homing T cell. In early-stage disease, lesions are limited to the skin, but in later-stage disease, the tumor cells can escape into the blood, the lymph nodes, and at times the visceral organs. To clarify the genomic basis of CTCL, we performed genomic analysis of 220 CTCLs. Our analyses identify 55 putative driver genes, including 17 genes not previously implicated in CTCL. These novel mutations are predicted to affect chromatin (BCOR, KDM6A, SMARCB1, TRRAP), immune surveillance (CD58, RFXAP), MAPK signaling (MAP2K1, NF1), NF-B signaling (PR...
Source: Blood - Category: Hematology Authors: Tags: Lymphoid Neoplasia Source Type: research
Ellie, who was diagnosed with Hodgkin Lymphoma when she was 15, describes the symptoms of blood cancer.
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
Conclusion In SIRIUS, no RBC transfusion reactions, including hemolysis, were observed. Observations from Mount Sinai and Levine Cancer Institute, confirm that transfusions may be administered safely to daratumumab-treated patients. Graphical abstract Teaser Daratumumab binds CD38 on red blood cells (RBCs), resulting in panagglutination in blood compatibility tests. RBC transfusions and transfusion-related adverse events from the phase 2 SIRIUS clinical trial were analyzed and an in-depth analysis from 2 clinical study sites is reported. RBC transfusion-related adverse events, including hemolysis, were not observed among d...
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
Conclusion CLAG plus IM was well tolerated, with encouraging signs of activity in patients with poor-risk AML.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
ConclusionsGiven the small existing cancer infrastructure, excessive mortality in Grenada compared to its neighbors may be disproportionately more attributable to low survival than a high cancer risk. Global solutions will be required to meet the cancer control needs of geographically isolated small nations such as Grenada.
Source: Cancer Causes and Control - Category: Cancer & Oncology Source Type: research
We describe 2 cases of nephrotic syndrome in patients treated with these agents. Patient 1 received the anti–PD-1 antibody pembrolizumab for Hodgkin lymphoma. Following his second dose, he developed nephrotic syndrome and acute kidney injury. Biopsy showed diffuse foot-process effacement consistent with minimal change disease and findings of acute tubular injury. Pembrolizumab therapy cessation and corticosteroid treatment yielded improvement in proteinuria and acute kidney injury. Patient 2 received the CTLA-4 antibody ipilimumab for melanoma. He developed nephrotic syndrome with biopsy changes consistent with minim...
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research
CONCLUSIONS: These obinutuzumab-based PET tracers have the ability to noninvasively and quantitatively monitor CD20-expression and have revealed insights into CD20 internalization upon antibody binding in vivo. Because they are based on a humanized mAb they have the potential for direct clinical translation and could improve patient selection for targeted therapy, dosimetry prior to radioimmunotherapy (RIT), and prediction of response to therapy. PMID: 28928164 [PubMed - as supplied by publisher]
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Tags: Clin Cancer Res Source Type: research
More News: Cancer | Cancer & Oncology | Health | Lymphoma